Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 3/2001

01-05-2001 | Originales

Multimodal treatment for squamous cell carcinoma of the esophagus: results with two different strategies

Authors: A. Font Pous, J. Fernández Llamazares, A. Arellano Tolivar, D. Casas Curtó, J. Boix Valverde, E. Mesalles Sanjuán, A Abad Esteve, R. Rosell Costa

Published in: Clinical and Translational Oncology | Issue 3/2001

Login to get access
Metadata
Title
Multimodal treatment for squamous cell carcinoma of the esophagus: results with two different strategies
Authors
A. Font Pous
J. Fernández Llamazares
A. Arellano Tolivar
D. Casas Curtó
J. Boix Valverde
E. Mesalles Sanjuán
A Abad Esteve
R. Rosell Costa
Publication date
01-05-2001
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 3/2001
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02711440

Other articles of this Issue 3/2001

Clinical and Translational Oncology 3/2001 Go to the issue

Revisiones

Breast cancer: contribution of molecular biology to the management of the disease

Announcement

Información

Notas Clínicas

Paraparesia secundaria a metástasis intramedular como manifestación inicial de un carcinoma microcítico de pulmón

Sección Docente

Isolation of circulating DNA in the serum of cancer patients

Editorial

The human genome and biomedicine: Future goals

Originales Breves

Hemangiomas vertebrales. Historia natural, diagnóstico y tratamiento. Papel de la radioterapia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits